Rowley SD - Search Results

1

Selection of normal human hematopoietic stem cells for bone marrow transplantation using immunomagnetic microspheres and CD34 antibody.

Strauss LC, Trischmann TM, Rowley SD, Wiley JM, Civin CI. Strauss LC, et al. Among authors: rowley sd. Am J Pediatr Hematol Oncol. 1991 Summer;13(2):217-21. doi: 10.1097/00043426-199122000-00018. Am J Pediatr Hematol Oncol. 1991. PMID: 1712550

2

Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.

Rowley SD, Piantadosi S, Marcellus DC, Jones RJ, Davidson NE, Davis JM, Kennedy J, Wiley JM, Wingard JR, Yeager AM, et al. Rowley SD, et al. Bone Marrow Transplant. 1991 Mar;7(3):183-91. Bone Marrow Transplant. 1991. PMID: 2059755

3

Treatment of poor prognosis non-Hodgkin's lymphoma using cyclophosphamide and total body irradiation regimens with autologous bone marrow rescue.

Braine HG, Santos GW, Kaizer H, Yeager AM, Mann RB, Burns WH, Civin CI, Fuller DJ, Rowley SD, Saral R, et al. Braine HG, et al. Among authors: rowley sd. Bone Marrow Transplant. 1987 Jun;2(1):7-14. Bone Marrow Transplant. 1987. PMID: 3332159

4

Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells.

Strauss LC, Rowley SD, La Russa VF, Sharkis SJ, Stuart RK, Civin CI. Strauss LC, et al. Among authors: rowley sd. Exp Hematol. 1986 Oct;14(9):878-86. Exp Hematol. 1986. PMID: 3758237

5

Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations.

Yeager AM, Rowley SD, Kaizer H, Santos GW. Yeager AM, et al. Among authors: rowley sd. Am J Pediatr Hematol Oncol. 1990 Fall;12(3):245-56. doi: 10.1097/00043426-199023000-00001. Am J Pediatr Hematol Oncol. 1990. PMID: 2240470 Review.

6

Isolation of human hematopoietic stem cells.

Bernstein ID, Andrews RG, Rowley S. Bernstein ID, et al. Blood Cells. 1994;20(1):15-23; discussion 24. Blood Cells. 1994. PMID: 7527677 Review.

7

Phase I study of combination drug purging for autologous bone marrow transplantation.

Rowley SD, Miller CB, Piantadosi S, Davis JM, Santos GW, Jones RJ. Rowley SD, et al. J Clin Oncol. 1991 Dec;9(12):2210-8. doi: 10.1200/JCO.1991.9.12.2210. J Clin Oncol. 1991. PMID: 1960561 Clinical Trial.

8

Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation.

Jones RJ, Zuehlsdorf M, Rowley SD, Hilton J, Santos GW, Sensenbrenner LL, Colvin OM. Jones RJ, et al. Among authors: rowley sd. Blood. 1987 Nov;70(5):1490-4. Blood. 1987. PMID: 3311205 Free article.

9

Using elutriation to engineer bone marrow allografts.

Noga SJ, Wagner JE, Rowley SD, Davis JM, Vogelsang GB, Hess AD, Saral R, Santos GW, Donnenberg AD. Noga SJ, et al. Among authors: rowley sd. Prog Clin Biol Res. 1990;333:345-59; discussion 360-1. Prog Clin Biol Res. 1990. PMID: 2137932 Clinical Trial.

10

Density-gradient separation of autologous bone marrow grafts before ex vivo purging with 4-hydroperoxycyclophosphamide.

Rowley SD, Davis JM, Piantadosi S, Jones RJ, Yeager AM, Santos GW. Rowley SD, et al. Bone Marrow Transplant. 1990 Nov;6(5):321-7. Bone Marrow Transplant. 1990. PMID: 2291993 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters